secwatch.observer — SEC 8-K summary
======================================

Issuer:     Syneos Health, Inc. (—)
CIK:        0001610950
Form:       8-K
Filed at:   2023-09-28T23:59:59+00:00
Accession:  0001193125-23-245005
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.01, 1.02, 2.01, 2.03, 3.01, 3.03, 5.01, 5.03, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Syneos Health completes $43.00/share all-cash acquisition; delisted from Nasdaq
-------------------------------------------------------------------------------

- Merger closed Sept 28, 2023; shareholders receive $43.00 per share in cash.
- Company became wholly owned subsidiary of Star Parent, Inc.
- New debt financing: $2.7B term loan, $500M revolver, $1B 9% Senior Secured Notes due 2030.
- Entire board resigned; new directors appointed including Colin Shannon and Michelle Keefe.
- Common stock delisted from Nasdaq; company intends to deregister under Section 12(b) of Exchange Act.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610950/000119312523245005/0001193125-23-245005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610950/000119312523245005/d559944d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-245005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer